Literature DB >> 3145866

Serological study of meningococcal isolates in Switzerland and France 1980-1986.

P Calain1, J Poolman, W Zollinger, G Sperber, D Bitter-Suermann, R Auckenthaler, B Hirschel.   

Abstract

A study was performed of 342 disease-related strains of meningococci isolated in Switzerland and France between 1980 and 1986, including more than 50% of all strains isolated in Switzerland in 1986. Using a newly developed spot-blot enzyme-linked immunoassay and a panel of monoclonal anti-meningococcal antibodies, 96% of all strains were shown to react with at least one antibody. In both countries more than 50% of the strains were group B. In France serotype 2a was the prevalent serotype and was often associated with subtype P1.2. In Switzerland serological markers of epidemic strains recently described in Northern Europe (serotype 15 and subtype P1.16) were observed with increasing frequency in 1986. However, serotype 4 has been prevalent in Switzerland since 1980 and no clonal population was seen to emerge.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145866     DOI: 10.1007/bf01975051

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

1.  [Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].

Authors:  G Schubiger; J Munzinger; C Dudli; U Wipfli
Journal:  Schweiz Med Wochenschr       Date:  1986-08-30

2.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Landmark perspective: The impact of penicillin on the treatment of meningitis.

Authors:  M G Täuber; M A Sande
Journal:  JAMA       Date:  1984-04-13       Impact factor: 56.272

4.  Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping.

Authors:  W D Zollinger; E E Moran; H Connelly; R E Mandrell; B Brandt
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Filter radioimmunoassay, a method for large-scale serotyping of Neisseria meningitidis.

Authors:  S de Marie; J H Hoeijmakers; J T Poolman; H C Zanen
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

6.  Meningococcal serotypes and serogroup B disease in north-west Europe.

Authors:  J T Poolman; I Lind; K Jónsdóttir; L O Frøholm; D M Jones; H C Zanen
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

7.  NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.

Authors:  M Frosch; I Görgen; G J Boulnois; K N Timmis; D Bitter-Suermann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

  7 in total
  2 in total

1.  A change in meningococcal serogroups in the west of Ireland?

Authors:  G Corbett-Feeney
Journal:  Ir J Med Sci       Date:  1991-05       Impact factor: 1.568

2.  Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies.

Authors:  J T Poolman; P Kriz-Kuzemenska; F Ashton; W Bibb; J Dankert; A Demina; L O Frøholm; M Hassan-King; D M Jones; I Lind
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.